2-chloro-n(6)cyclopentyladenosine has been researched along with Coronary Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Downey, JM; Liu, Y | 1 |
| Downey, JM; Liu, GS; Olsson, RA; Thornton, JD | 1 |
| Mullane, K | 1 |
3 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and Coronary Disease
| Article | Year |
|---|---|
Ischemic preconditioning protects against infarction in rat heart.
Topics: Adaptation, Physiological; Adenosine; Animals; Coronary Disease; Glyburide; Heart; In Vitro Techniques; Male; Myocardial Infarction; Purinergic Antagonists; Rats; Rats, Sprague-Dawley; Tachycardia, Ventricular; Ventricular Fibrillation | 1992 |
Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction.
Topics: Adenosine; Animals; Coronary Disease; Female; Heart; Hemodynamics; Injections, Intravenous; Male; Myocardial Infarction; Phenethylamines; Phenylisopropyladenosine; Rabbits | 1992 |
Myocardial preconditioning. Part of the adenosine revival.
Topics: Adenosine; Adenosine Triphosphate; Animals; Coronary Disease; Heart; Humans; Myocardium; Receptors, Purinergic | 1992 |